Skip to content

Neogen NEOG Total Equity

Total Equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$51.93B+5.2%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$1.56B+7.5%
Zoetis logo
ZoetisZTS
$3.23B-30.5%
Revvity logo
RevvityRVTY
$7.18B-5.9%
Agilent Technologies logo
Agilent TechnologiesA
$7.12B+16.1%
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's total equity?
Neogen (NEOG) reported total equity of $2.1B in Q4 2025.
How has Neogen's total equity changed year-over-year?
Neogen's total equity decreased by 21.0% year-over-year, from $2.66B to $2.1B.
What is the long-term trend for Neogen's total equity?
Over 4 years (2021 to 2025), Neogen's total equity has grown at a 25.3% compound annual growth rate (CAGR), from $840.38M to $2.07B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.